Equity Brief · Healthcare2026-05-20
RMD·Healthcare

ResMed Inc

I · KI-Analyse

Kurzfassung

ResMed manufactures devices that help people breathe better during sleep—primarily CPAP machines and other equipment for sleep apnea—and also sells cloud-based software that home health agencies, nursing homes, and medical equipment suppliers use to manage patient records and billing [Yahoo Finance]. They operate in two main segments: Sleep and Breathing Health (the devices) and Residential Care Software (the healthcare management systems).

ResMed is a $30.1 billion medical device company that makes equipment to treat sleep apnea and other breathing disorders, along with software for home healthcare providers [Yahoo Finance]. The company just announced a partnership with Oura, a wearable ring maker, to screen for sleep problems earlier and expand its customer base beyond traditional doctor referrals [Simply Wall St]. Financially, ResMed is exceptionally strong with 27% profit margins, $1.7 billion in free cash flow, and a perfect 10/10 health score [Yahoo Finance].

ResMed is in outstanding financial shape with strong profitability, excellent cash generation, and essentially no net debt.

Kurzfassung AI analysisKonfidenz 8/10

Sentinellis-Score

10/10

Financially healthy

Marktkapitalisierung

$30.1B

Umsatz (12 Monate)

$5.1B

II · Aktuelle Nachrichten

Was den Kurs bewegt hat

3 stories · ranked by relevance

  • macro2026-05-20

    ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access

    Simply Wall St

  • macro2026-05-19

    Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

    Yahoo Finance

  • macro2026-05-19

    Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

    Yahoo Finance

Premium · kostenlos mit jedem Konto

The stock has declined nearly 20% over the past three months despite strong fundamentals, indicating investors may be concerned about growth sustainability or competitive pressures not yet visible in the financial data [Simply Wall St].

1 von 4 Risiken in diesem Bericht

Risiken

4

Chancen

4

Warnsignale

1

Führung

10

18 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.

Vollständige ResMed Inc-Analyse freischalten

Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.

  • 4 Risiken, 4 Chancen und 1 Warnsignal — jeweils mit Quelle
  • Über 100 Finanzkennzahlen mit Charts und Vergleichen
  • Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
  • Führungsteam und Vergütung
  • PDF-Export für offline
Alle 9 Erkenntnisse freischalten3 kostenlose Berichte · keine Karte

III · Ähnliche Unternehmen

Das könnte Sie auch interessieren

Same sector · Healthcare or comparable health

Auf Ihre Watchlist setzen?

Read three companies free. Keine Karte.

3 kostenlose Berichte sichern